Search research articles
Contact Us
Filters
Showing results (61-70 of 152) with videos related to
Page
of 16
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 15, 2013
Detection of circulating tumor cells harboring a unique ALK rearrangement in ALK-positive non-small-cell lung cancer
Emma Pailler, Julien Adam, Amélie Barthélémy, et al.
Cancer Research
|
May 25, 2017
Immune Checkpoint Blockade, Immunogenic Chemotherapy or IFN-α Blockade Boost the Local and Abscopal Effects of Oncolytic Virotherapy
Laetitia Fend, Takahiro Yamazaki, Christelle Remy, et al.
Molecular Cancer Therapeutics
|
May 27, 2020
An Antibody-Drug Conjugate Targeting MUC1-Associated Carbohydrate CA6 Shows Promising Antitumor Activities
Céline Nicolazzi, Anne Caron, Alexia Tellier, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
October 29, 2017
Prognostic value of tissue necrosis, hypoxia-related markers and correlation with HPV status in head and neck cancer patients treated with bio- or chemo-radiotherapy
Dan Ou, Ingrid Garberis, Julien Adam, et al.
Oncoimmunology
|
September 22, 2017
Clinical relevance of tumor infiltrating lymphocytes, PD-L1 expression and correlation with HPV/p16 in head and neck cancer treated with bio- or chemo-radiotherapy
Dan Ou, Julien Adam, Ingrid Garberis, et al.
Cardiovascular and Interventional Radiology
|
November 7, 2019
Correction to: Focus on Recommendations for the Management of Non-small Cell Lung Cancer
Pernelle Lavaud, Benjamin Besse, Thierry de Baere, et al.
Frontiers in Immunology
|
March 21, 2020
IDO Targeting in Sarcoma: Biological and Clinical Implications
Imane Nafia, Maud Toulmonde, Doriane Bortolotto, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 23, 2019
Baseline metabolic tumor burden on FDG PET/CT scans predicts outcome in advanced NSCLC patients treated with immune checkpoint inhibitors
Romain-David Seban, Laura Mezquita, Arnaud Berenbaum, et al.
Cancer Biomarkers : Section a of Disease Markers
|
November 2, 2016
MMS19 as a potential predictive marker of adjuvant chemotherapy benefit in resected non-small cell lung cancer
Julien Adam, Tony Sourisseau, Ken A Olaussen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 1, 2017
Antitumour activity of somatostatin analogues in sporadic, progressive, metastatic pulmonary carcinoids
Ivana Sullivan, Gwénaël Le Teuff, Joël Guigay, et al.
Page
of 16
Search research articles
Search
Showing results (61-70 of 152) with videos related to
Sort By:
Page
of 16
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 15, 2013
Detection of circulating tumor cells harboring a unique ALK rearrangement in ALK-positive non-small-cell lung cancer
Emma Pailler, Julien Adam, Amélie Barthélémy, et al.
Cancer Research
|
May 25, 2017
Immune Checkpoint Blockade, Immunogenic Chemotherapy or IFN-α Blockade Boost the Local and Abscopal Effects of Oncolytic Virotherapy
Laetitia Fend, Takahiro Yamazaki, Christelle Remy, et al.
Molecular Cancer Therapeutics
|
May 27, 2020
An Antibody-Drug Conjugate Targeting MUC1-Associated Carbohydrate CA6 Shows Promising Antitumor Activities
Céline Nicolazzi, Anne Caron, Alexia Tellier, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
October 29, 2017
Prognostic value of tissue necrosis, hypoxia-related markers and correlation with HPV status in head and neck cancer patients treated with bio- or chemo-radiotherapy
Dan Ou, Ingrid Garberis, Julien Adam, et al.
Oncoimmunology
|
September 22, 2017
Clinical relevance of tumor infiltrating lymphocytes, PD-L1 expression and correlation with HPV/p16 in head and neck cancer treated with bio- or chemo-radiotherapy
Dan Ou, Julien Adam, Ingrid Garberis, et al.
Cardiovascular and Interventional Radiology
|
November 7, 2019
Correction to: Focus on Recommendations for the Management of Non-small Cell Lung Cancer
Pernelle Lavaud, Benjamin Besse, Thierry de Baere, et al.
Frontiers in Immunology
|
March 21, 2020
IDO Targeting in Sarcoma: Biological and Clinical Implications
Imane Nafia, Maud Toulmonde, Doriane Bortolotto, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 23, 2019
Baseline metabolic tumor burden on FDG PET/CT scans predicts outcome in advanced NSCLC patients treated with immune checkpoint inhibitors
Romain-David Seban, Laura Mezquita, Arnaud Berenbaum, et al.
Cancer Biomarkers : Section a of Disease Markers
|
November 2, 2016
MMS19 as a potential predictive marker of adjuvant chemotherapy benefit in resected non-small cell lung cancer
Julien Adam, Tony Sourisseau, Ken A Olaussen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 1, 2017
Antitumour activity of somatostatin analogues in sporadic, progressive, metastatic pulmonary carcinoids
Ivana Sullivan, Gwénaël Le Teuff, Joël Guigay, et al.
Page
of 16